Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Eterna Therapeutics Inc. is a preclinical-stage biotech company developing allogeneic mesenchymal stem cell (iMSC) therapies for cancer and autoimmune diseases. Its core focus is on off-the-shelf cellular treatments leveraging iPSC-derived stem cells to target solid tumors and inflammation. The company emphasizes innovative gene editing, nucleic acid technologies, and strategic partnerships to advance its pipeline and intellectual property portfolio.
This description was generated via AI from an annual report. Updated about 1 year ago.